Biden administration stacked vaccine advisory committee with new members

Taking stock of the drug industry, from the lab to the medicine chest

January 31, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Alex Wong/Getty Images With little fanfare, Biden administration stacked vaccine advisory committee with new members The burst of activity could, in theory, make it more difficult for the Trump administration to shape the panel with its own appointees. By Helen Branswell and Sarah Owermohle STAT+ | Vertex wins FDA approval for non-opioid pain drug, setting stage for closely watched rollout Analysts who are bullish on the drug argue there's real need for non-addictive alternatives to opioid painkillers By Jonathan Wosen STAT+ | RFK Jr. says U.S. won't threaten pharmaceutical patents to push for lower drug prices The use of march-in rights to target pricy drugs has been a controversial issue across several administrations. By Rachel Cohrs Zhang JOSEPH PREZIOSO/AFP via Getty Images STAT+ | Vertex, U.K. reach reimbursement deal for CRISPR-based medicine for sickle cell disease Patients in England with the inherited blood disorder will now be able to get the world's first CRISPR-based treatment through the NHS. By Andrew Joseph Opinion: How to protect HHS, FDA, NIH, and other health agencies from political interference There is an urgent need to implement safeguards that protect the FDA, CDC, and other agencies from political interference. By Anushka Bhaskar, Aaron S. Kesselheim, and Daniel Carpenter

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser